Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Sirolimus is commonly used to treat lymphangiomyomatosis and used as prevention of kidney transplant rejection.
Sirolimus is a macrolide that is able to suppress our immune mediators, subsequently suppresses the over-activation of our immune system.
Increased risk of infection, Hypokalaemia, Dyslipidaemia, Hypophosphataemia, Hyperglycaemia, Headache, Gut disturbances, Liver dysfunction, Skin rash, Joint pain, Proteinuria, Menstrual disorder, Oedema, Anaemia/Low platelet/Low white blood cell
There is no known interaction between alcohol and Sirolimus when used concomitantly. However, it is not advisable to use alcohol during the treatment of Lymphangiomyomatosis and after kidney transplant.
Animal studies have shown reproductive toxicities and there are limited data on the use of Sirolimus in pregnant women. Thus, Sirolimus is not advisable to be used during pregnancy. Please consult your doctor.
Excretion of Sirolimus has been found in animal milk but it is unknown in human breast milk. To prevent the potential of adverse effect on breastfed babies, it is advisable not to use Sirolimus during breastfeeding. Please consult your doctor.
Sirolimus usually does not affect the ability to drive. Do not drive unless you are feeling well.
Sirolimus is safe to be used in patients with kidney impairment.
Caution use and dose adjustment are needed for patients with liver impairment. Please consult your doctor.